Noxafil and Abdominal distension - a phase IV clinical study of FDA data

Summary:

Abdominal distension is reported as a side effect among people who take Noxafil (posaconazole), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Abdominal distension when taking Noxafil. It is created by eHealthMe based on reports of 5,902 people who have side effects when taking Noxafil from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Abdominal distension?

Abdominal distension is found to be associated with 2,565 drugs and 3,644 conditions by eHealthMe. Check the latest studies of Abdominal distension.

On Jul, 26, 2026

5,902 people reported to have side effects when taking Noxafil.
Among them, 43 people (0.73%) have Abdominal distension.

Could Noxafil cause Abdominal distension?

Among these 43 people:

How long have people been on Noxafil when they have Abdominal distension? *

What is the gender of people who have Abdominal distension when taking Noxafil? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Abdominal distension when taking Noxafil? *

What are other drugs people take besides Noxafil? *

What are other side effects people have besides Abdominal distension? *

Diarrhea: 12 people, 27.91%
Dyspnea (difficult or laboured breathing): 11 people, 25.58%
Fever: 10 people, 23.26%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 9 people, 20.93%
Haematuria (presence of blood in urine): 8 people, 18.60%
Abdominal Pain: 8 people, 18.60%
Weight Increased: 8 people, 18.60%
Thrombocytopenia (decrease of platelets in blood): 8 people, 18.60%
Cough: 7 people, 16.28%
Indigestion: 7 people, 16.28%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 20.93%
Cytomegalovirus Infection: 7 people, 16.28%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 6 people, 13.95%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 11.63%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 3 people, 6.98%
Infection: 3 people, 6.98%
Hodgkin's Lymphoma (cancer originating from white blood cells): 3 people, 6.98%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 4.65%
Erythema Nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below): 1 person, 2.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and have Abdominal distension?

- Check whether Abdominal distension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Noxafil:

Noxafil (5,919 reports)

Browse all side effects of Noxafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal distension:

Abdominal distension (2,565 drugs)

Browse all the conditions that are associated with Abdominal distension:

Abdominal distension (3,644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole (the active ingredients of Noxafil) and Noxafil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.